Striatal Blood–Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background: Parkinson's disease (PD) exhibits a high prevalence of dementia as disease severity and duration progress. Focused ultrasound (FUS) has been applied for transient blood–brain barrier (BBB) opening of cortical regions in neurodegenerative disorders. The striatum is a primary target for delivery of putative therapeutic agents in PD. Objective: Here, we report a prospective, single‐arm, nonrandomized, proof‐of‐concept, phase I clinical trial (NCT03608553 amended) in PD with dementia to test the safety and feasibility of striatal BBB opening in PD patients. Methods: Seven PD patients with cognitive impairment were treated for BBB opening in the posterior putamen. This was performed in two sessions separated by 2 to 4 weeks, where the second session included bilateral putamina opening in 3 patients. Primary outcome measures included safety and feasibility of focal striatal BBB opening. Changes in motor and cognitive functions, magnetic resonance imaging (MRI), 18 F‐fluorodopa (FDOPA), and β‐amyloid PET (positron emission tomography) images were determined. Results: The procedure was feasible and well tolerated, with no serious adverse events. No neurologically relevant change in motor and cognitive (battery of neuropsychological tests) functions was recognized at follow‐up. MRI revealed putamen BBB closing shortly after treatment (24 hours to 14 days) and ruled out hemorrhagic and ischemic lesions. There was a discrete but significant reduction in β‐amyloid uptake in the targeted region and no change in FDOPA PET. Conclusions: These initial results indicate that FUS‐mediated striatal BBB opening is feasible and safe and therefore could become an effective tool to facilitate the delivery of putative neurorestorative molecules in PD. © 2022 International Parkinson and Movement Disorder Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blood-brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound
Lipsman, N., Meng, Y., Bethune, A. J., Huang, Y., Lam, B., Masellis, M., Herrmann, N., Heyn, C., Aubert, I., Boutet, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04529-6 · Cited by 950
CSF, blood-brain barrier, and brain drug delivery
Pardridge, W. M. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1171315 · Cited by 508 · cited 1×
“The blood–brain barrier (BBB) largely limits the access of putative therapeutic molecules to the brain.(1) In recent years, the combination of focused ultrasound (FUS) and intravenously injected microbubbles has been shown to disrupt the BBB transiently at specific brain targets.”
BackgroundScanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model
Leinenga, G., & Götz, J. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa2512 · Cited by 498
Abrahao, A., Meng, Y., Llinas, M., Huang, Y., Hamani, C., Mainprize, T., Aubert, I., Heyn, C., Black, S. E., Hynynen, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12426-9 · Cited by 476
Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound.
Rezai, A. R., Ranjan, M., D’Haese, P.-F., Haut, M. W., Carpenter, J., Najib, U., Mehta, R. I., Chazen, J. L., Zibly, Z., Yates, J. R., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002571117 · Cited by 365
Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia
Gasca-Salas, C., Fernández-Rodríguez, B., Pineda-Pardo, J. A., Rodríguez-Rojas, R., Obeso, I., Hernández-Fernández, F., del Álamo, M., Mata, D., Guida, P., Ordás-Bandera, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21022-9 · Cited by 319
Self-citationBurgess, A., Dubey, S., Yeung, S., Hough, O., Eterman, N., Aubert, I., & Hynynen, K. (2014) · Radiology · doi:10.1148/radiol.14140245 · Cited by 286 · cited 2×
“On the contrary, although BBB opening is mainly envisaged for facilitating brain access to putative therapies, it is associated experimentally and in AD patients(8) with reduction in amyloid extracellular deposition.(9,10) This effect against AD pathology appears to be enhanced in mice by concomitant delivery of antib…”
BackgroundResultMotor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Blesa, J., Foffani, G., Dehay, B., Bezard, E., & Obeso, J. A. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00542-9 · Cited by 232 · cited 1×
“In such circumstances, synuclein aggregates and related pathology are not necessarily widespread.(33) Therefore, targeting the nigrostriatal dopaminergic projection seems to be a reasonable approach, at least as a proof of principle.”
BackgroundSelf-citationNisbet, R. M., Van der Jeugd, A., Leinenga, G., Evans, H. T., Janowicz, P. W., & Götz, J. (2017) · Brain · doi:10.1093/brain/awx052 · Cited by 187
Park, S. H., Baik, K., Jeon, S., Chang, W. S., Ye, B. S., & Chang, J. W. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00269-8 · Cited by 95
Onset pattern of nigrostriatal denervation in early Parkinson’s disease
Pineda-Pardo, J. A., Sánchez-Ferro, Á., Monje, M. H. G., Pavese, N., & Obeso, J. A. (2022) · Brain · doi:10.1093/brain/awab378 · Cited by 51 · cited 1×
“Thus, in the future, BBB opening should probably be applied early after diagnosis in relatively young (<60 years) PD patients in whom typically focal motor features predominate(30,31) and are associated with focal dopaminergic denervation in the mid-motor putamen contralateral to the affected body side.(32) In such ci…”
BackgroundSelf-citation
Cited by
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Zha, S., Liu, H., Li, H., Li, H., Wong, K.-L., & All, A. H. (2024) · ACS Nano · doi:10.1021/acsnano.3c10674 · Cited by 378
Focused ultrasound blood-brain barrier opening: a review of post-procedure MRI outcomes
LeBlang, S., Mehta, R. I., D’haese, P.-F., Grinspan, A., Sokolov, A., & Frazzetta, G. (2026) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2026.2737272
Desale, S. H., Doshi, P. P., Khutale, A. A., & Suresh, S. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103379
Metadata
- Authors
- Pineda‐Pardo, J. A., Gasca‐Salas, C., Fernández‐Rodríguez, B., Rodríguez‐Rojas, R., del Álamo, M., Obeso, I., Hernández‐Fernández, F., Trompeta, C., Martínez‐Fernández, R., Matarazzo, M., Mata‐Marín, D., Guida, P., Duque, A., Albillo, D., Plaza de las Heras, I., Montero, J. I., Foffani, G., Toltsis, G., Rachmilevitch, I., Blesa, J., & Obeso, J. A.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2022-06-28
- Volume
- 37
- Issue
- 10
- Pages
- 2057-2065
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W4283690139
- Cited by
- 75
- References
- 11
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.